BLACKROCK NORTH AMERICAN INCOME TRUST PLC
All information is at 30 November 2013 and unaudited.
Performance at month end with net income reinvested
One Three Six Since
Month months months launch
(24Oct2012)
Net asset value 0.7% 2.8% 0.0% 17.9%
Share price 2.4% 2.5% 0.3% 19.4%
Russell 1000 Value Index 0.8% 3.9% 2.3% 28.4%
Source: BlackRock
At month end
Net asset value - capital only: 111.31p
Net asset value - cum income: 111.79p
Share price: 115.25p
Premium to cum income NAV: 3.1%
Net yield*: 3.5%
Total assets including current year revenue: £111.4m
Target yield**: 4.00%
Gearing: 0.4%
Options overwrite: 17.47%
Ordinary shares in issue: 99,611,305
During the month, the company has issued 250,000 shares for proceeds of £0.3m
*based on dividends of 1p per share each declared on 14 February 2013, 14 May
2013, 6 August 2013 and 3 October 2013
** based on issue price of 100p
Sector Analysis Total Assets (%)
Financials 21.9
Industrials 14.5
Energy 13.7
Consumer Staples 11.5
Consumer Discretionary 9.4
Health Care 9.2
Materials 6.9
Utilities 5.7
Information Technology 5.3
Telecommunication Services 3.4
Net current liabilities -1.5
-----
100.0
=====
Country Analysis Total Assets (%)
USA 93.4
Canada 2.6
Australia 1.6
France 1.5
United Kingdom 1.3
Netherlands 0.9
Peru 0.2
Net current liabilities -1.5
-----
100.0
=====
Ten Largest Investments(in alphabetical order)
Company Country of Risk
Chevron USA
Comcast USA
Exxon Mobil USA
General Electric USA
Home Depot USA
JPMorgan Chase USA
Merck USA
Pfizer USA
Prudential Financial USA
Wells Fargo USA
Bob Shearer and Kathleen Anderson, representing the Investment Manager, noted:
Performance
For the month ended 30 November 2013, the Company posted a 0.7% increase in its
NAV while the share price increased by 2.4% (all in sterling). The Company's
benchmark, the Russell 1000 Value Index, returned 0.8% for the period.
On a relative basis, the largest contributor to the Company's performance was
stock selection in the financials sector. Top performers included Prudential
Financial, Inc. and JPMorgan Chase & Co. Stock selection in the consumer
discretionary and industrials sectors also added to relative returns, as did
stock selection in utilities and telecommunication services.
The largest detractor from relative performance was stock selection in the
consumer staples sector, particularly in the tobacco industry. A combination of
stock selection and an underweight to the health care sector also hurt relative
returns, as did our overweight to the materials sector. Lastly, an underweight
to financials modestly detracted from relative returns.
Transactions/Options
Transactions: During the month, we increased our weighting to General Electric
Company and reduced our weighting to Unilever NV. This was the only notable
transaction in the period.
As at 30 November 2013, the Company's options exposure was 17.47% and the delta
of the options was 91.15%.
Positioning
The Company is currently overweight to the consumer staples, industrials,
materials, consumer discretionary and telecommunication services sectors. We
are underweight to the financials, health care, information technology energy
and utilities sectors.
20 December 2013
ENDS
Latest information is available by typing www.blackrock.co.uk/brna on the
internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV
terminal). Neither the contents of the Manager's website nor the contents of
any website accessible from hyperlinks on the Manager's website (or any other
website) is incorporated into, or forms part of, this announcement.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.